DEBBANE RAYMOND (CIK 1053890) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-27). Recent activity: Buy LXRX (2,000 shares), Buy LXRX (100,000 shares), Buy LXRX (50,000 shares), Buy LXRX (100,000 shares), Buy LXRX (57,952 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 2,000 | $2,980 |
| 2026-02-25 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 100,000 | $147,000 |
| 2026-02-23 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 50,000 | $72,000 |
| 2026-02-23 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 100,000 | $148,000 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 57,952 | $75,917 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 76,857 | $100,683 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 133,688 | $176,468 |
| 2026-02-06 | Scholar Rock Holding Corp (SRRK) | Insider | Buy | 1.6M | $11.6M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 18.6M | $24.1M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 3.8M | $5.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 1.5M | $2.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 367,145 | $0 |
| 2025-05-13 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Director | Buy | 36,810 | $0 |
Source: SEC Form 4 filings · as of 2026-02-27